Strut Health
Ranked #9 · Grade B−
Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.
- $30/mo cheaper than MEDGm
- scores 80/100 against MEDGm's 42
Trimi Health
Ranked #10 · Grade B−
The price-first pick: some of the lowest flat, all-inclusive compounded pricing we track, nationwide — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
- $4/mo cheaper than MEDGm
- scores 80/100 against MEDGm's 42
ShedRx
Ranked #13 · Grade C
The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.
- scores 76/100 against MEDGm's 42
SynergyRX
Ranked #14 · Grade C
Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.
- scores 76/100 against MEDGm's 42
telos rx
Ranked #16 · Grade C
Four flat, posted price points across semaglutide and three tirzepatide formats, with a written promise the cost won't climb with your dose — a real step up in clarity from what we found last check — undercut by a state list it still won't publish.
- $80/mo cheaper than MEDGm
- scores 75/100 against MEDGm's 42
⛔ FDA warning letter #728279 (June 2026), which names tryeden.com. The most oversight-forward compounded program here — visible clinician involvement and lab framing — at $196/mo semaglutide or $296/mo tirzepatide, flat and nationwide.
- scores 89/100 against MEDGm's 42
Breeze Meds
Ranked #11 · Grade C
A clean, all-50-states compounded option with named pharmacies, no membership and the consult included — reasonable and transparent on price, though it's a newer platform with thin public detail beyond the $199 headline.
- scores 78/100 against MEDGm's 42
yourEra
Ranked #15 · Grade C
A low-entry, all-in compounded program with both molecules and a clean cancel-anytime policy — appealing if the starting price holds, but the ongoing rate isn't published and the outcome claims are unverified marketing.
- $80/mo cheaper than MEDGm
- scores 76/100 against MEDGm's 42
YourHealthRx
Ranked #96 · Grade C
A science-forward compounded shop with a broad peptide catalog and flat dosing — $170/mo semaglutide, $210/mo tirzepatide ongoing — but the homepage 'as low as' price is a promotional rate, and there's no postpartum or PCOS-specific content.
- $9/mo cheaper than MEDGm
- scores 50/100 against MEDGm's 42